A PHASE 3, RANDOMIZED, DOUBLE-BLIND, THIRD PARTY UNBLIND TRIAL TO EVALUATE THE SAFETY AND IMMUNOGENICITY OF A 20-VALENT PNEUMOCOCCAL CONJUGATE VACCINE IN HEALTHY JAPANESE INFANTS
A PHASE 3, RANDOMIZED, DOUBLE-BLIND, THIRD PARTY UNBLIND TRIAL TO EVALUATE THE SAFETY AND IMMUNOGENICITY OF A 20-VALENT PNEUMOCOCCAL CONJUGATE VACCINE IN HEALTHY JAPANESE INFANTS
20-valent Pneumococcal Conjugate Vaccine Safety and Immunogenicity Study in Healthy Japanese Infants
Inclusion Criteria:
Exclusion Criteria:
Toyota-shi, Aichi-ken 471-8513, Japan
Yotsukaido-shi, Chiba 284-0001, Japan
Yotsukaido-shi, Chiba 284-0003, Japan
Ebetsu Shi, Hokkaido 069-0816, Japan
Kawasaki-shi, Kanagawa 211-0063, Japan
Ureshino-shi, Saga-ken 843-0393, Japan
Hanyu-shi, Saitama 348-0045, Japan
Kumagaya-shi, Saitama 360-0018, Japan
Ritto-Shi, Shiga 520-3046, Japan
Setagaya-ku, Tokyo 154-0002, Japan
Setagaya-ku, Tokyo 157-0066, Japan
Shinjuku-ku, Tokyo 160-0017, Japan
Suginami-ku, Tokyo 167-0052, Japan
Tsuru-shi, Yamanashi 402-0025, Japan